GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » YoY EBITDA Growth

Cantourage Group SE (XTER:HIGH) YoY EBITDA Growth : 0.00% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cantourage Group SE's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 0.00%.

Cantourage Group SE's EBITDA per Share for the six months ended in Jun. 2023 was €0.00.

Cantourage Group SE YoY EBITDA Growth Historical Data

The historical data trend for Cantourage Group SE's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE YoY EBITDA Growth Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
YoY EBITDA Growth Get a 7-Day Free Trial - - - - -

Cantourage Group SE YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cantourage Group SE's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-)/ | |
=N/A %

Cantourage Group SE's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantourage Group SE (XTER:HIGH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » YoY EBITDA Growth
Comparable Companies
Traded in Other Exchanges
HIGH:Germany
Address
Feurigstrasse 54, Berlin, DEU, 10827
Website
https://www.cantourage.com
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines